NM

Newtyn Management Portfolio holdings

AUM $817M
1-Year Est. Return 19.88%
This Quarter Est. Return
1 Year Est. Return
+19.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$660M
AUM Growth
+$27.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
40
New
Increased
Reduced
Closed

Top Buys

1
+$25.7M
2
+$14.1M
3
+$14.1M
4
SITC icon
SITE Centers
SITC
+$12.4M
5
MAGN
Magnera Corp
MAGN
+$11.7M

Top Sells

1
+$34M
2
+$27.5M
3
+$18.9M
4
TSVT
2seventy bio
TSVT
+$12.5M
5
CLFD icon
Clearfield
CLFD
+$8.92M

Sector Composition

1 Healthcare 28.7%
2 Real Estate 17.14%
3 Consumer Discretionary 15.18%
4 Communication Services 11.81%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITOS
26
DELISTED
iTeos Therapeutics
ITOS
$5.66M 0.86%
+567,416
RCKT icon
27
Rocket Pharmaceuticals
RCKT
$429M
$4.9M 0.74%
+2,000,000
MITK icon
28
Mitek Systems
MITK
$469M
$4.8M 0.73%
484,954
-236,600
KROS icon
29
Keros Therapeutics
KROS
$595M
$3.3M 0.5%
+246,857
ABEO icon
30
Abeona Therapeutics
ABEO
$281M
$2.73M 0.41%
480,000
WVE icon
31
Wave Life Sciences
WVE
$2.7B
$2.6M 0.39%
400,000
AVIR icon
32
Atea Pharmaceuticals
AVIR
$277M
$2.09M 0.32%
580,000
ETNB
33
DELISTED
89bio
ETNB
$1.96M 0.3%
200,000
MURA
34
DELISTED
Mural Oncology
MURA
$1.41M 0.21%
570,000
USAR
35
USA Rare Earth Inc
USAR
$2.54B
– –
-692,650
CLFD icon
36
Clearfield
CLFD
$449M
– –
-300,000
GLPG icon
37
Galapagos
GLPG
$2.25B
– –
-200,000
THRD
38
DELISTED
Third Harmonic Bio
THRD
– –
-635,150
TSVT
39
DELISTED
2seventy bio
TSVT
– –
-2,534,836
VTOL icon
40
Bristow Group
VTOL
$1.17B
– –
-18,080
1
2